Copy
PCI Ventures Summer 2014 Newsletter
View this email in your browser
PCI Ventures
PCI Ventures, a division of the Penn Center for Innovation, offers a suite of services to promote entrepreneurship and to incubate Penn technologies through company creation, entrepreneurial education, and hands-on support.

In This Issue

  • UPstart Is Now Part of PCI Ventures!
  • MABA's 1st Pitch Life Science Comes to Philadelphia
    Graphene Frontiers Completes Series B Financing
  • Helar Technologies Announces Licensing Deal
  • Rescufy Wins AppItUP Challenge
  • Resuscor Engages CTO; Presents at CONVERGE 2014
  • MobileOptx Announces First Sale
  UPSTART
  APPITUP 
  UPADVISORS
Subscribe to our newsletter
UPstart
UPstart is Now a Part of PCI Ventures!
PCI Ventures was launched on June 2nd 2014 as a functional division of the Penn Center for Innovation (PCI), tasked with promoting and supporting entrepreneurial activities and company formation around Penn intellectual property. PCI Ventures encompasses UPstart, UPadvisors, AppItUP, and newly developing entrepreneurial education and support programs. For our clients, collaborators and friends, the familiar faces are still here and working on expanding the scope of services that we bring to you.
 
1st Pitch
Mid Atlantic Bio Angels’ (MABA) 1st Pitch Life Science Comes to Philadelphia
Ever wonder what happens after a company presents to an investor group? Typically, after a start-up company’s team leaves the room, investors have a private discussion about whether the opportunity merits further investigation and possible investment. 1st Pitch Life Science offers local presenters and audience participants the chance to listen in on those closed door discussions and to learn what really matters to investors. Following its success in NYC and based on demand from the local life science community, MABA’s 1st Pitch Life Science is expanding to Philadelphia. The first event will be held on September 16th, 2014 at 5:30 to 8:30 pm in the offices of BakerHostetler in the Cira Center. Attendance is free but you must preregister; companies interested in applying please email PAinfo@1stpitchlifescience.com.
 
Graphene Frontiers
Graphene Frontiers Completes Series B Financing
Graphene Frontiers has completed a Series B funding round totaling $1.6MM. The Company is a global leader in the production of graphene for commercial and industrial applications. Under the leadership of CEO Mike Patterson, the current funding will enable production of the next generation of biological and chemical sensor technology for the life science, defense, intelligence, and environmental industries. The company is headquartered in Philadelphia, PA. Read the CNBC article here.
 
Helar Technologies
Helar Technologies, LLC Announces Licensing Deal
Helar Technologies announces execution of a license agreement with the University of Chicago/Argonne National Laboratories. The company is developing a portable device for therapeutic cooling, which could deliver much needed temperature control to minimally invasive/laparoscopic procedures, thus increasing operable surgery window, improving outcomes for patients and reducing recovery time.
 
MobileOptx
MobileOptx, LLC Announces First Sale
MobileOptx, makers of smartphone compatible endoscopic adapters to capture, review and share images, is excited to announce the launch of its first device.  MobileOptx allows the professional to capture high resolution stills and videos at the bedside to review later with colleagues, insert into the medical records or instantly show the patient what was seen during the exam.  The company was founded by Drs. Natasha Mirza and Jason Brant of the Department of Otorhinolaryngology at the Hospital of the University of Pennsylvania, and is led by entrepreneur Dr. Jodi Cook.  For more information about purchasing a device or investing, visit www.mobileoptx.com or contact Dr. Cook.


The MobileOptx endoscopic adapter with iPhone
 
Rescufy
Rescufy Wins AppItUP Challenge

Rescufy won the 2013-14 AppItUP challenge, out-competing almost 200 ideas for digital apps from the Penn community. The winning concept and prototype were selected by a group of prominent area investors and software developers. Rescufy was created by David and Rachel Edwards who were inspired by their son, Sammy, to simplify the standard anaphylaxis action plan. Sammy has a life threatening tree nut allergy. With Rescufy’s emergency mobile application for allergy and asthma they would have a simple, fast, and reliable tool to streamline getting help in the event of anaphylaxis. Rescufy's beta app for Android is lined up for release in the early fall. You can still sign up to be a beta tester at www.rescufy.com.

Alex Karpovsky, CEO of Kanda Software;
Sheree Revilla, CEO of Rescufy; David
Edwards, Founder of Rescufy

 
Resuscor
Resuscor Engages CTO; Presents at CONVERGE 2014
Resuscor LLC has engaged Rick O’Brien, a serial entrepreneur and experienced software developer, to lead the development and launch of the company’s suite of products including the first mobile application for targeted temperature management. The application is designed to guide and support clinicians during the administration of life-saving clinical protocols with an initial focus on cardiac indications. The Company was chosen as one of 2014’s top start-up companies by CONVERGE and invited to present its products at the CONVERGE healthcare innovation conference in Philadelphia in July, 2014. For more information, see their web site www.resuscor.com
 
Copyright © 2014 PCI Ventures at the Pennovation Center, All rights reserved.


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp